Share-based Payment Arrangement, Expense of INTERPACE BIOSCIENCES, INC. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
INTERPACE BIOSCIENCES, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • INTERPACE BIOSCIENCES, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $7,000, a 92% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $104,000, a 70% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. annual Share-based Payment Arrangement, Expense for 2024 was $291,000, a 54% decline from 2023.
  • INTERPACE BIOSCIENCES, INC. annual Share-based Payment Arrangement, Expense for 2023 was $630,000, a 47% decline from 2022.
  • INTERPACE BIOSCIENCES, INC. annual Share-based Payment Arrangement, Expense for 2022 was $1,191,000, a 15% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

INTERPACE BIOSCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $104,000 $7,000 -$79,000 -92% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $183,000 $9,000 -$44,000 -83% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $227,000 $15,000 -$64,000 -81% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $291,000 $73,000 -$56,000 -43% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $347,000 $86,000 -$66,000 -43% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $413,000 $53,000 -$104,000 -66% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $517,000 $79,000 -$113,000 -59% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $630,000 $129,000 +$47,000 +57% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $583,000 $152,000 -$349,000 -70% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $932,000 $157,000 -$148,000 -49% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $1,080,000 $192,000 -$111,000 -37% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $1,191,000 $82,000 +$315,000 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $876,000 $501,000 +$73,000 +17% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $803,000 $305,000 -$246,000 -45% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $1,049,000 $303,000 +$17,000 +5.9% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $1,032,000 $233,000 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $428,000 -$135,000 -24% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $551,000 +$151,000 +38% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $286,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 $563,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $400,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2018 $1,560,000 $600,000 +$500,000 +500% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $1,060,000 $560,000 01 Oct 2017 31 Dec 2017 10-K 21 Mar 2019 2018 FY
Q3 2017 $300,000 +$100,000 +50% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $100,000 -$100,000 -50% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 $100,000 $0 0% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q3 2016 $200,000 -$100,000 -33% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $200,000 -$300,000 -60% 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017 2017 Q2
Q1 2016 $100,000 -$100,000 -50% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q3 2015 $300,000 01 Jul 2015 30 Sep 2015 10-Q 17 Nov 2016 2016 Q3
Q2 2015 $500,000 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $200,000 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1

INTERPACE BIOSCIENCES, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $291,000 -$339,000 -54% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $630,000 -$561,000 -47% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $1,191,000 +$159,000 +15% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $1,032,000 -$1,155,000 -53% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2020 $2,187,000 +$652,000 +42% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $1,535,000 -$199,000 -11% 01 Jan 2019 31 Dec 2019 10-K 01 Apr 2021 2020 FY
2018 $1,734,000 +$674,000 +64% 01 Jan 2018 31 Dec 2018 10-K/A 19 Jan 2021 2019 FY
2017 $1,060,000 01 Jan 2017 31 Dec 2017 10-K 21 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.